Fidelity SPDR Advertisement
Home > Boards > US Listed > Telecommunications Hardware >

Kallo, Inc. (KALO)

KALO RSS Feed
Add KALO Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator
Search This Board:
Last Post: 10/31/2014 11:18:30 AM - Followers: 77 - Board type: Free - Posts Today: 6

Kallo, Inc. (KALO) leverages a suite of technologies to improve the quality and efficiency of care in the $6.3 trillion global healthcare industry. Offering centralized, congruent solutions that attend healthcare and business issues, the company addresses the needs of hospitals, ministries of health, physicians, and other healthcare organizations.

As a result of an expanding and aging population, coupled with an increasing number of people suffering from chronic diseases and lifestyle related conditions, healthcare expenditures continue to grow. Kallo is focused on introducing new healthcare technology that helps contain costs, enable better methods to monitor/treat medical conditions, and increase the reach of healthcare providers to remote areas.

The tailored solutions offered by Kallo complement existing infrastructure, workflows, and processes, increasing both uptime and productivity. The company’s suite of products complies with international, national, and regional standards, and its stringent quality control ensures repeatable, process-driven delivery for maximum performance.

Kallo’s executives and directors bring rich and diverse industry knowledge. Collectively, the management team reflects the strength of the company’s global network and the diversity of its global culture. The team’s entrepreneurship, passion, experience, and knowledge of healthcare enable Kallo to continually deliver higher standards.

 


Investment Highlights

  • Diverse Product Portfolio Allows Entrance Into Key Markets
    Guided by Proficient, Experienced Management Team
    Intuitive Technology Designed to Enhance Life
    Innovatively Addressing Global Medical Concerns
    Mobile Medical Solutions Applicable Worldwide

 


Solutions

Powerful Portfolio of Technologies Address Global Healthcare Concerns

Kallo’s tailored solutions provide efficient delivery of healthcare services. The company’s technologies complement existing infrastructure, workflows and processes increasing uptime and productivity. All of Kallo’s clinical solutions are in compliance with international, national, and regional standards. The company’s stringent quality control ensures repeatable, process-driven delivery for maximum performance.

!ntegraat

!ntegraat enables any medical device to connect to any EMR, PACS, HIS, RIS, PIS or DI-r, providing a seamless flow of information and data that ensures clinicians have all the needed information to provide patients timely and effective healthcare.

 

Kallo MobileCare™

Kallo MobileCare™ is a comprehensive solution for remote and unreached communities. These mobile clinics are fully equipped with best-in-class medical devices and congruent information systems enabling the centralized coordination of resources and communications through Administration Centres.

The Clinical Command Centres provide support from medical specialists for complex cases through HL7, DICOM, HIPAA (among others) compliant information & telemedicine systems.

Kallo MobileCare™ is deployed with a full training program for ultimate adoption success incorporating medical and technical best practices from across the globe.

 

Kallo Rural-Care MRHDS (Modular Rural Healthcare Delivery Systems)

Kallo Rural-Care MRHDS are pre-fabricated, pre-tested, modular and project determined medical clinics. They are installed with the latest medical equipment from X-Ray and ultrasound to surgery, lab and pharmacy equipment. Based on project requirement, these clinics range from 1200 to 3800 square feet, and can be implemented in rural or disaster-struck areas in a week.

These medical clinics are prefabricated to include a patient exam room, operating room, imaging room, laboratory and dispensary. The staff quarters features a kitchenette, laundry and shower.

 

CygnaMed™

Globalization, inexpensive travel, high treatment costs, long wait times and lack of access to medical facilities have fuelled Medical Tourism to an approx. $25 billion industry. Producing stronger revenues than traditional tourism, Medical Tourism is attractive for many countries seeking to expand economic benefits.

 

oHealth

oHealth provides the infrastructure, technology, training and support to seamlessly integrate with any clinic, laboratory, specialty, hospital, repository or regional and national Health Information Access Layer (HIAL).

 

Keristää™

Keristää is software developed for the collection, integration and communication of clinical information in emergency conditions. The software enables close and instantaneous monitoring of infectious disease outbreaks. Keristää detects and identifies threats at various ports of entry and alerts the Centre for Disease Control/Ministry of Health. Utilizing this data, the software provides physicians the ability to ensure that treatment is based on latest CDC & WHO protocols.

 


Market Opportunity

Global Expenditures for Healthcare Above $6.3 Trillion, U.S. Leads Spending

The global healthcare system is increasingly overburdened with rising numbers of people suffering from chronic diseases and lifestyle related conditions. Due to an expanding and aging global population, healthcare expenditures continue to grow.

The U.S. devotes far more of its economy -- 17.6 percent of GDP in 2010 -- to health than any other country, according to the most recent report from the Organization for Economic Co-operation and Development (OECD).

As budgets tighten and costs rise, developments in healthcare technology help contain costs, contribute to the development of better methods to monitor/treat medical conditions, and increase the reach of healthcare providers to remote areas.

Kallo’s suite of products - including four copyrighted technologies - is positioned to serve this growing medical technology sector. Through innovation, telecommunication, technology and Total Quality Management, Kallo enables a seamless flow of information/data providing clinicians with all needed information to provide patients timely and effective healthcare.

In providing these technologies, the company has secured the opportunity to participate in several multi-billion dollar market segments.

 


Management Team

The members of Kallo’s management team have rich and diverse industry knowledge, delivering an unprecedented level of commitment and value to the company’s customers and shareholders. These remarkable people reflect the strength of Kallo’s global network and the diversity of its global culture. They have a special responsibility to act with integrity, accept accountability, insist on excellence, support innovation and lead by example.

 

JJohn Cecil - Chairman and CEO, Member of the Board of Directors

With a Bachelor’s degree in electrical engineering, a Master of Science degree in biomedical engineering and a Post Graduate Diploma in medical equipment technology, John Cecil has been in the healthcare industry for 26 years. He is responsible for the invention of the technology and procedure behind depth-of-anesthesia monitoring and non-invasive blood group testing, and was part of the research team that developed the electro-hydraulic shockwave lithotripter, laser lithotripter and transurethral microwave therapy systems. Following a distinguished career, holding such positions as vice president and director with major players in India including GE Medical Systems and Majoris Systems, Cecil immigrated to Canada in 2003 to continue his research and work on several products he is developing. Since then, he has served as director of healthcare with leading software services provider Satyam Computer Service Ltd. and senior healthcare solutions architect with Sun Microsystems. In April 2009, Cecil made the decision to devote his efforts exclusively to the development of a series of breakthrough technologies he has been working on, which are built for use in healthcare management.

 

Vince Leitao - President and COO, Member of the Board of Directors

Having worked in senior sales and marketing roles in the pharmaceutical, medical, and healthcare businesses for 32 years, Vince Leitao is a seasoned business executive. He began his sales career in Goa, India, and has extensive experience strategizing, planning and executing challenging sales and marketing plans. Over his career he has demonstrated an ability to develop and grow new business opportunities and products, and is able to identify, train, motivate and retain the best talent. Since moving to Canada in 1990, Leitao has worked with major companies such as Procter & Gamble and E. Merck, as well as sales director and vice president of sales for Genpharm/Gennium Pharma. He was promoted to director of sales for doubling sales in his territory over the previous year for three straight years. Besides regional players, Leitao has worked and built relations with large medical/pharmaceutical channel partners. He is also the founder of Goapharma, a producer and marketer of specialty dermatology products for very difficult to treat conditions like psoriasis and eczema. He is a hands-on executive who willingly steps in to help close a sale or change a light bulb. A gold medalist public speaker, Leitao is fluent in five languages. His drive, planning and determination are vital contributors to the success of Kallo Inc.

 

Samuel R. Baker - Secretary and Legal Counsel, Member of the Board of Directors

Samuel R. Baker, Q.C., B.A., L.L.B., has been in the legal field for 48 years. He is a senior partner with Baker Law Firm, has provided legal counsel to numerous Fortune 500 and other multinational corporations, and is a founding member and Canadian representative to the Asia-Pacific Lawyers’ Association. He is also the director of the Canada-Netherlands and Canada-Finland Chambers of Commerce, and is the president of the Canada Scandinavian Business Association. His fellowships include: Teaching Fellow (Stanford 1962-63), Alberta Bar (1962), Ontario Bar (1966), and Fellow, Patent and Trademark Institute of Canada (1982). Baker is the author of books and articles on international transactions, joint ventures, technology transfers, establishing a business in Canada, among many other subjects.

 

Lloyd Chiotti – Member of the Board of Directors

Lloyd Chiotti holds an engineering degree and an MBA, both from the University of Toronto. He has worked with Enbridge Gas Distribution (formerly The Consumers Gas Company) for over 30 years. Over the course of his career he has held a number of senior management positions including director of Information Services and a number of regional general manager roles within operations. Most recently he was appointed to the newly formed position of director, distribution asset management, responsible for overseeing the development of Enbridge Gas Distribution’s Strategic Asset Plan. He is actively involved in the natural gas industry. He is currently the dhair of the Asset Management Task Force of the Canadian Gas Association and he is a member of the Distribution Working Committee of the International Gas Union. Throughout his career he has also served on the boards of a number of not-for-profit organizations including: president, Alternative Computer Training for the Disabled; chair, United Way of Peel Campaign 1992; chair of the Board, West Park Healthcare Centre Foundation; vice-chair of the board, Junior Achievement of Toronto; and chair of the board, Toronto Mendelssohn Choir.

 


Kallo, Inc.
15 Allstate Parkway
Suite 600
Markham, ON L32 5B4 Canada
(212) 519-9864
www.KalloInc.ca
Info@KalloInc.ca

 

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
KALO
Current Price
Volume:
Bid Ask Day's Range
Wiki
KALO News: Securities Registration Statement (s-1) 10/30/2014 10:25:22 AM
KALO News: Withdrawal of Registration Statement (rw) 10/16/2014 03:52:21 PM
KALO News: Securities Registration Statement (s-1/a) 09/24/2014 03:24:21 PM
KALO News: Securities Registration Statement (s-1) 08/25/2014 04:57:41 PM
KALO News: Quarterly Report (10-q) 08/14/2014 05:04:47 PM
PostSubject
#3540   314k Traded! Chris1968 10/31/14 11:18:30 AM
#3539   Whyever the Train is Leaving the Station Chris1968 10/31/14 10:42:04 AM
#3538   Something is going on! Chris1968 10/31/14 10:40:19 AM
#3537   272k Traded! Chris1968 10/31/14 10:38:42 AM
#3536   Sold earlier than I should have, patience ran onlywayup 10/31/14 10:32:28 AM
#3535   Again 140k Traded. This Morning! Something is going on. Chris1968 10/31/14 10:18:06 AM
#3534   It would be nice to break even, at bh2614 10/30/14 03:34:06 PM
#3533   149k Traded Today. Usuelly First Volume than PPS Chris1968 10/30/14 02:53:11 PM
#3532   33,000 shares traded today. Must be management bh2614 10/29/14 02:20:36 PM
#3531   We seem to have lost nearly a year. Sage7243 10/23/14 07:49:36 PM
#3528   I have 13k left I would love to Chris1968 10/23/14 01:25:11 PM
#3527   i still hold the shares but gave up... shl468 10/23/14 12:55:41 PM
#3526   hope so too. lets move back to ten..:)) Chris1968 10/22/14 04:09:04 PM
#3525   211,000 shares already onlywayup 10/22/14 11:26:30 AM
#3524   After the Registration Statement is updated, they can Man99 10/22/14 10:25:52 AM
#3523   AN update would be nice. Sage7243 10/21/14 09:19:27 PM
#3522   My 6,300 shares are now worth $336 now, bh2614 10/21/14 02:12:03 PM
#3521   If you didnt get out before now you mdipa417 10/21/14 01:57:11 PM
#3520   Agreed. Plus they couldn't or wouldn't sell bh2614 10/21/14 12:26:54 PM
#3519   Dealing with African countries means working on African Man99 10/20/14 04:49:26 PM
#3518   This stock is dead in the water countries mdipa417 10/20/14 03:49:44 PM
#3517   Why? To me it sounds like an administrative filing. Isca 10/20/14 11:18:37 AM
#3516   Canada to Ship Experimental Ebola Vaccine to World Man99 10/20/14 10:02:26 AM
#3515   This can't be good! October 16, 2014 United States Securities and Wattsup99 10/17/14 05:27:04 PM
#3514   C'Mon WHO! You are now my/our only hope. Sage7243 10/16/14 10:05:54 PM
#3513   This one is looking more and more like trizzy83 10/15/14 09:41:55 AM
#3512   Anybody call KALO lately?, I got put on andy e 10/14/14 12:20:01 PM
#3511   Yea its an Ebola play alright, cause its fingers 10/13/14 06:14:30 PM
#3510   1000% gainer? Never ever know with these crazy markets. vulken17 10/13/14 06:06:50 PM
#3509   KALO. Next Ebola Play? Chris1968 10/13/14 03:53:40 PM
#3508   I don't know about a scam. I think Sage7243 10/13/14 03:06:12 PM
#3507   DILUTION: Issuing a million shares a week! NOTE 9 SeaOhToo 10/13/14 01:28:49 PM
#3506   Found this news in the latest 8-k, SeaOhToo 10/09/14 04:31:41 PM
#3505   anything Kallo? any news? shl468 10/09/14 10:57:10 AM
#3504   Not looking good :( trizzy83 10/06/14 09:55:45 AM
#3503   Will we ever see the PPS rise? No onlywayup 10/03/14 04:52:13 AM
#3502   I'm excited for the wait! penny149 10/02/14 10:27:11 AM
#3501   Kalo in 6 months will have hit big mdipa417 09/30/14 06:22:19 PM
#3500   http://blogs.state.gov/stories/2014/09/26/grand-challenge-help-health-care-worke vulken17 09/29/14 10:32:25 AM
#3499   10k is great.::)) So let's do it again.::)) Chris1968 09/28/14 06:20:46 AM
#3498   In January, I made 10k on KALO. Derekski0125 09/26/14 07:26:24 PM
#3497   You are probably right but until now I Chris1968 09/25/14 02:08:45 AM
#3496   From News today: I think if Kodiak spends Chris1968 09/25/14 02:07:19 AM
#3495   So much no out there in other stocks Derekski0125 09/24/14 08:42:45 PM
#3494   to compare it with the last weeks volume Chris1968 09/24/14 01:22:19 PM
#3493   80,100 shares moved on a stock Derekski0125 09/23/14 08:42:55 PM
#3492   Nice Upmove today with good volume..:)) Chris1968 09/23/14 03:51:15 PM
#3491   "Patients are being rejected... because there is no blackjackmagraw 09/21/14 02:36:32 PM
#3490   Selling those shares will do you good. Derekski0125 09/20/14 10:41:31 AM
#3489   Fine. I will agree with you, if bh2614 09/18/14 11:45:27 AM
PostSubject